Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy
- PMID: 16609904
- DOI: 10.1007/s00417-006-0311-9
Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy
Abstract
Background: The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).
Methods: Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.
Results: Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.
Conclusions: Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.
Similar articles
-
Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):237-43. doi: 10.1007/s00417-007-0651-0. Epub 2007 Aug 3. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17674018
-
Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.Arch Ophthalmol. 2006 Apr;124(4):487-92. doi: 10.1001/archopht.124.4.487. Arch Ophthalmol. 2006. PMID: 16606873
-
Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.Am J Ophthalmol. 2007 Apr;143(4):701-4. doi: 10.1016/j.ajo.2006.10.045. Epub 2006 Nov 28. Am J Ophthalmol. 2007. PMID: 17386286
-
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.Curr Drug Targets. 2011 Feb;12(2):149-72. doi: 10.2174/138945011794182746. Curr Drug Targets. 2011. PMID: 20887246 Review.
-
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].Ophthalmologe. 2004 Feb;101(2):113-20. doi: 10.1007/s00347-003-0982-0. Ophthalmologe. 2004. PMID: 14991306 Review. German.
Cited by
-
Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1165-71. doi: 10.1007/s00417-009-1089-3. Epub 2009 Apr 29. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19404661
-
Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.Br J Ophthalmol. 2006 Nov;90(11):1357-60. doi: 10.1136/bjo.2006.092536. Epub 2006 Aug 2. Br J Ophthalmol. 2006. PMID: 16885191 Free PMC article.
-
The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):89-92. doi: 10.1007/s00417-007-0638-x. Epub 2007 Jul 25. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17653567
-
Visual and morphological outcomes of bevacizumab (Avastin®) versus ranibizumab (Lucentis®) treatment for retinal angiomatous proliferation.Int Ophthalmol. 2012 Jun;32(3):259-68. doi: 10.1007/s10792-012-9562-0. Epub 2012 Apr 18. Int Ophthalmol. 2012. PMID: 22527448
-
Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1877-80. doi: 10.1007/s00417-007-0679-1. Epub 2007 Sep 28. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17901972
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical